Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status

JAMA

Volumn 308, Issue 10, 2012, Pages 973-975

  Greene, Jeremy A ^a,c   Choudhry, Niteesh K ^a   Kesselheim, Aaron S ^a   Brennan, Troyen A ^b   Shrank, William ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CVS Caremark   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; GENERIC DRUG; LORATADINE; NON PRESCRIPTION DRUG; OMEPRAZOLE; TETRAHYDROLIPSTATIN;

CONSUMER HEALTH INFORMATION; COST BENEFIT ANALYSIS; DRUG IDENTIFICATION; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG MISUSE; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; LETTER; ONLINE SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84866060706     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.10647     Document Type: Letter

References (6)

1. IMS Health. Total US promotional spending by type. http://www.imshealth. com/deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top- line%20Market%20Data/2010%20Top-line%20Market%20Data/2010-Promotional-Data.pdf. Accessed December 1, 2011.
2. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-681.
3. VMS. Adsight Product Sheet. New York, NY: VMS; 2010.
4. Faerber AE, Kreling DH. Now you see it: now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter. Health Commun. 2012;27(1):66-74.
5. World Health Organization. Ethical criteria for medicinal drug promotion. http://archives.who.int/tbs/promo/whozip08e.pdf. Accessed July 5, 2012.
6. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar-pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321-2324.